000 01684 a2200469 4500
005 20250514020130.0
264 0 _c20020102
008 200201s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/s0006-2952(01)00796-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPiao, W
245 0 0 _aInduction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells.
_h[electronic resource]
260 _bBiochemical pharmacology
_cDec 2001
300 _a1439-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
650 0 4 _aCDC2 Protein Kinase
_xmetabolism
650 0 4 _aCaspase 3
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aG2 Phase
_xdrug effects
650 0 4 _aHL-60 Cells
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aLeukemia, Promyelocytic, Acute
650 0 4 _aMitosis
_xdrug effects
650 0 4 _aPoly (ADP-Ribose) Polymerase-1
650 0 4 _aPoly(ADP-ribose) Polymerases
650 0 4 _aProteins
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xbiosynthesis
650 0 4 _aSulfones
_xpharmacology
700 1 _aYoo, J
700 1 _aLee, D K
700 1 _aHwang, H J
700 1 _aKim, J H
773 0 _tBiochemical pharmacology
_gvol. 62
_gno. 11
_gp. 1439-47
856 4 0 _uhttps://doi.org/10.1016/s0006-2952(01)00796-1
_zAvailable from publisher's website
999 _c11642408
_d11642408